CA2423806A1 - Modified carbocyanine dyes and their conjugates - Google Patents
Modified carbocyanine dyes and their conjugates Download PDFInfo
- Publication number
- CA2423806A1 CA2423806A1 CA 2423806 CA2423806A CA2423806A1 CA 2423806 A1 CA2423806 A1 CA 2423806A1 CA 2423806 CA2423806 CA 2423806 CA 2423806 A CA2423806 A CA 2423806A CA 2423806 A1 CA2423806 A1 CA 2423806A1
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- sulfo
- amino
- independently
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000298 carbocyanine Substances 0.000 title abstract 2
- QWYZFXLSWMXLDM-UHFFFAOYSA-M pinacyanol iodide Chemical class [I-].C1=CC2=CC=CC=C2N(CC)C1=CC=CC1=CC=C(C=CC=C2)C2=[N+]1CC QWYZFXLSWMXLDM-UHFFFAOYSA-M 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 39
- 239000000126 substance Substances 0.000 claims abstract 14
- 239000000975 dye Substances 0.000 claims abstract 4
- -1 hydroxy, carboxy, sulfo Chemical group 0.000 claims 64
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 40
- 125000004429 atom Chemical group 0.000 claims 24
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 23
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims 21
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 20
- 229910052736 halogen Inorganic materials 0.000 claims 20
- 150000002367 halogens Chemical class 0.000 claims 20
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 18
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 18
- 125000004754 (C2-C12) dialkylamino group Chemical group 0.000 claims 17
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 claims 16
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 14
- 229920006395 saturated elastomer Polymers 0.000 claims 14
- 229910052801 chlorine Inorganic materials 0.000 claims 12
- 229910052731 fluorine Inorganic materials 0.000 claims 12
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 11
- 125000005842 heteroatom Chemical group 0.000 claims 11
- 150000003839 salts Chemical class 0.000 claims 11
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 claims 10
- 108091034117 Oligonucleotide Proteins 0.000 claims 10
- 229910052794 bromium Inorganic materials 0.000 claims 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims 10
- 102000004856 Lectins Human genes 0.000 claims 9
- 108090001090 Lectins Proteins 0.000 claims 9
- 102000034287 fluorescent proteins Human genes 0.000 claims 9
- 108091006047 fluorescent proteins Proteins 0.000 claims 9
- 229910052740 iodine Inorganic materials 0.000 claims 9
- 239000002523 lectin Substances 0.000 claims 9
- 239000002773 nucleotide Substances 0.000 claims 9
- 125000003729 nucleotide group Chemical group 0.000 claims 9
- 229910052760 oxygen Inorganic materials 0.000 claims 9
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 9
- 229940126586 small molecule drug Drugs 0.000 claims 9
- 229910052717 sulfur Inorganic materials 0.000 claims 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 239000012634 fragment Substances 0.000 claims 8
- 229910019142 PO4 Inorganic materials 0.000 claims 7
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 7
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims 7
- 125000005605 benzo group Chemical group 0.000 claims 7
- 125000004093 cyano group Chemical group *C#N 0.000 claims 7
- 150000002148 esters Chemical class 0.000 claims 7
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 7
- 229910052757 nitrogen Inorganic materials 0.000 claims 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 7
- 239000010452 phosphate Substances 0.000 claims 7
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 claims 7
- 150000001412 amines Chemical class 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 6
- 125000004663 dialkyl amino group Chemical group 0.000 claims 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims 6
- 125000005208 trialkylammonium group Chemical group 0.000 claims 6
- 238000000034 method Methods 0.000 claims 5
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 5
- 239000000523 sample Substances 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 4
- AFCIMSXHQSIHQW-UHFFFAOYSA-N [O].[P] Chemical compound [O].[P] AFCIMSXHQSIHQW-UHFFFAOYSA-N 0.000 claims 4
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical compound N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 claims 4
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims 4
- 125000004122 cyclic group Chemical group 0.000 claims 4
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- DOTMOQHOJINYBL-UHFFFAOYSA-N molecular nitrogen;molecular oxygen Chemical compound N#N.O=O DOTMOQHOJINYBL-UHFFFAOYSA-N 0.000 claims 4
- OTYNBGDFCPCPOU-UHFFFAOYSA-N phosphane sulfane Chemical compound S.P[H] OTYNBGDFCPCPOU-UHFFFAOYSA-N 0.000 claims 4
- 229910052698 phosphorus Inorganic materials 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 150000003568 thioethers Chemical class 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 125000004104 aryloxy group Chemical group 0.000 claims 3
- 239000012472 biological sample Substances 0.000 claims 3
- 150000007976 iminium ions Chemical class 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 3
- 229910052697 platinum Inorganic materials 0.000 claims 3
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims 2
- 108090001008 Avidin Proteins 0.000 claims 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims 2
- 229920002307 Dextran Polymers 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 2
- 108090000790 Enzymes Proteins 0.000 claims 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims 2
- 108010090804 Streptavidin Proteins 0.000 claims 2
- 102000023732 binding proteins Human genes 0.000 claims 2
- 108091008324 binding proteins Proteins 0.000 claims 2
- 229960002685 biotin Drugs 0.000 claims 2
- 235000020958 biotin Nutrition 0.000 claims 2
- 239000011616 biotin Substances 0.000 claims 2
- 125000004181 carboxyalkyl group Chemical group 0.000 claims 2
- 239000002158 endotoxin Substances 0.000 claims 2
- 239000007850 fluorescent dye Substances 0.000 claims 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
- 229920006008 lipopolysaccharide Polymers 0.000 claims 2
- 244000005700 microbiome Species 0.000 claims 2
- 239000011859 microparticle Substances 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- 229930195734 saturated hydrocarbon Natural products 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 239000003053 toxin Substances 0.000 claims 2
- 231100000765 toxin Toxicity 0.000 claims 2
- 229930195735 unsaturated hydrocarbon Natural products 0.000 claims 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims 1
- 102000007469 Actins Human genes 0.000 claims 1
- 108010085238 Actins Proteins 0.000 claims 1
- 102400000068 Angiostatin Human genes 0.000 claims 1
- 108010079709 Angiostatins Proteins 0.000 claims 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims 1
- 102400001047 Endostatin Human genes 0.000 claims 1
- 108010079505 Endostatins Proteins 0.000 claims 1
- 102000028555 IgG binding proteins Human genes 0.000 claims 1
- 108091009325 IgG binding proteins Proteins 0.000 claims 1
- 102000003797 Neuropeptides Human genes 0.000 claims 1
- 108090000189 Neuropeptides Proteins 0.000 claims 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims 1
- 101710172711 Structural protein Proteins 0.000 claims 1
- 125000003282 alkyl amino group Chemical group 0.000 claims 1
- 150000001350 alkyl halides Chemical class 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 150000008064 anhydrides Chemical class 0.000 claims 1
- 150000001502 aryl halides Chemical class 0.000 claims 1
- FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 claims 1
- 150000001540 azides Chemical class 0.000 claims 1
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 claims 1
- 239000012503 blood component Substances 0.000 claims 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 239000002532 enzyme inhibitor Substances 0.000 claims 1
- 229940125532 enzyme inhibitor Drugs 0.000 claims 1
- 238000001215 fluorescent labelling Methods 0.000 claims 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 1
- 239000011521 glass Substances 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 claims 1
- 150000002463 imidates Chemical class 0.000 claims 1
- 239000012948 isocyanate Substances 0.000 claims 1
- 150000002513 isocyanates Chemical class 0.000 claims 1
- 150000002540 isothiocyanates Chemical class 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 238000002493 microarray Methods 0.000 claims 1
- 239000004005 microsphere Substances 0.000 claims 1
- 229920001542 oligosaccharide Polymers 0.000 claims 1
- 150000002482 oligosaccharides Chemical class 0.000 claims 1
- 230000003287 optical effect Effects 0.000 claims 1
- 102000036213 phospholipid binding proteins Human genes 0.000 claims 1
- 108091011000 phospholipid binding proteins Proteins 0.000 claims 1
- 150000008300 phosphoramidites Chemical class 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 229910052710 silicon Inorganic materials 0.000 claims 1
- 239000010703 silicon Substances 0.000 claims 1
- 230000009870 specific binding Effects 0.000 claims 1
- 238000010186 staining Methods 0.000 claims 1
- 150000003461 sulfonyl halides Chemical class 0.000 claims 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 1
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical group C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract 1
- 230000021615 conjugation Effects 0.000 abstract 1
- 230000003595 spectral effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C66/00—Quinone carboxylic acids
- C07C66/02—Anthraquinone carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/54—Spiro-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/96—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/13—Labelling of peptides
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/02—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/02—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
- C09B23/06—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups three >CH- groups, e.g. carbocyanines
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/02—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
- C09B23/08—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines
- C09B23/083—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines five >CH- groups
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/10—The polymethine chain containing an even number of >CH- groups
- C09B23/107—The polymethine chain containing an even number of >CH- groups four >CH- groups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6825—Nucleic acid detection involving sensors
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B70/00—Tags or labels specially adapted for combinatorial chemistry or libraries, e.g. fluorescent tags or bar codes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
- G01N2001/302—Stain compositions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
- G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Abstract
Chemically reactive carbocyanine dyes incorporating an indolium ring moiety that is substituted at the 3-position by a reactive group or by a conjugated substance, and their uses, are described. Conjugation through this position results in spectral properties that are uniformly superior to those of conjugates of spectrally similar dyes wherein attachment is at a different position. The invention includes derivative compounds having one or more benzo nitrogens.
Claims (42)
1. A compound of the formula:
and its salts, wherein R3 is -L-R x; or -L-S c; and R4 is independently -L-R x; or -L-S c; or a C1-C22 alkyl or C7-C22 arylalkyl, each alkyl portion of which optionally incorporates up to six hetero atoms, selected from N, O and S, and each alkyl portion of which is optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, phosphate, amino, sulfate, phosphonate, cyano, nitro, azido, C1-C6 alkoxy, C1-C6 alkylamino, or C2-C12 dialkylamino, or C3-C18 trialkylammonium; or R3 and R4 taken in combination complete a five- or six-membered saturated or unsaturated ring that is substituted by -L-R x; or -L-S c; and L is a single covalent bond, or a covalent linkage that is linear or branched, cyclic or heterocyclic, saturated or unsaturated, having 1-16 nonhydrogen atoms selected from the group consisting of C, N, P, O, and S, such that the linkage contains any combination of ether, thioether, amine, ester, amide bonds; or single, double, triple or aromatic carbon-carbon bonds; or phosphorus-oxygen, phosphorus-sulfur, nitrogen-nitrogen, nitrogen-oxygen, or nitrogen-platinum bonds; or aromatic or heteroaromatic bonds;
R x is a reactive group;
S c is a conjugated substance;
Y represents the atoms necessary to form one to two fused aromatic rings having 6 atoms in each ring, which atoms are selected from -CH, -C, -CR1, and -N(R2).beta., where each .beta. is 0 or 1, and each R1 is independently -L-R x; or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
each R2, when present (where .alpha. or .beta. is 1), is independently -L-R x;
or -L-S c; or a C1-C22 alkyl or C7-C22 arylalkyl, each alkyl portion of which optionally incorporates up to six hetero atoms, selected from N, O and S, and each alkyl portion of which is optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, phosphate, amino, sulfate, phosphonate, cyano, nitro, azido, C1-C6 alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, or C3-C18 trialkylammonium;
.alpha. is 0 or 1, and .alpha. + all .beta. = 1; and W represents the atoms necessary to form one to two fused aromatic rings having 6 atoms in each ring, which atoms are selected from -CH, -C, -CR1', and -N(R12).beta.', where each .beta.' is 0 or 1, and each R1' is independently -L-R x; or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
each R12, when present (where .delta. or .beta.' is 1), is independently -L-R
x; or -L-S c; or is a C1-C22 alkyl or C7-C22 arylalkyl, each alkyl portion of which optionally incorporates up to six hetero atoms, selected from N, O and S, and each alkyl portion of which is optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, phosphate, amino, sulfate, phosphonate, cyano, nitro, azido, C1-C6 alkoxy, C1-alkylamino, C2-C12 dialkylamino, or C3-C18 trialkylammonium;
.delta. is 0 or 1, and .delta. + all .beta.' = 1;
Z is O, S, or CR13R14;
R13 and R14 are independently -L-R x ; or -L-S c ; or a C1-C22 alkyl or C7-C22 arylalkyl, each alkyl portion of which optionally incorporates up to six hetero atoms, selected from N, O and S, and each alkyl portion of which is optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, phosphate, amino, sulfate, phosphonate, cyano, nitro, azido, C1-C6 alkoxy, C1-C8 alkylamino, or C2-C12 dialkylamino, or C3-C18 trialkylammonium; or R13 and R14 taken in combination complete a five- or six-membered saturated or unsaturated ring that is optionally substituted by -L-R x; or -L-S c;
n is 1, 2 or 3; and each R21, R22, and R23 is independently H, F, Cl, C1-C6 alkyl, C1-C6 alkoxy, aryloxy, a nitrogen heterocycle, an iminium ion, -L-R x, or -L-S c; or any two adjacent substituents of R21, R22, R23, when taken in combination, forms a 4-, 5-, or 6-membered saturated or unsaturated hydrocarbon ring that is optionally substituted one or more times by C1-C6 alkyl, halogen, or a carbonyl oxygen; or R21 taken in combination with R4 forms a 6-membered ring that is optionally substituted by C1-C6 alkyl; or one of R23, whichever is adjacent to Z, taken in combination with one of R13 and R14 forms a 6-membered ring that is optionally substituted by C1-C6 alkyl.
and its salts, wherein R3 is -L-R x; or -L-S c; and R4 is independently -L-R x; or -L-S c; or a C1-C22 alkyl or C7-C22 arylalkyl, each alkyl portion of which optionally incorporates up to six hetero atoms, selected from N, O and S, and each alkyl portion of which is optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, phosphate, amino, sulfate, phosphonate, cyano, nitro, azido, C1-C6 alkoxy, C1-C6 alkylamino, or C2-C12 dialkylamino, or C3-C18 trialkylammonium; or R3 and R4 taken in combination complete a five- or six-membered saturated or unsaturated ring that is substituted by -L-R x; or -L-S c; and L is a single covalent bond, or a covalent linkage that is linear or branched, cyclic or heterocyclic, saturated or unsaturated, having 1-16 nonhydrogen atoms selected from the group consisting of C, N, P, O, and S, such that the linkage contains any combination of ether, thioether, amine, ester, amide bonds; or single, double, triple or aromatic carbon-carbon bonds; or phosphorus-oxygen, phosphorus-sulfur, nitrogen-nitrogen, nitrogen-oxygen, or nitrogen-platinum bonds; or aromatic or heteroaromatic bonds;
R x is a reactive group;
S c is a conjugated substance;
Y represents the atoms necessary to form one to two fused aromatic rings having 6 atoms in each ring, which atoms are selected from -CH, -C, -CR1, and -N(R2).beta., where each .beta. is 0 or 1, and each R1 is independently -L-R x; or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
each R2, when present (where .alpha. or .beta. is 1), is independently -L-R x;
or -L-S c; or a C1-C22 alkyl or C7-C22 arylalkyl, each alkyl portion of which optionally incorporates up to six hetero atoms, selected from N, O and S, and each alkyl portion of which is optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, phosphate, amino, sulfate, phosphonate, cyano, nitro, azido, C1-C6 alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, or C3-C18 trialkylammonium;
.alpha. is 0 or 1, and .alpha. + all .beta. = 1; and W represents the atoms necessary to form one to two fused aromatic rings having 6 atoms in each ring, which atoms are selected from -CH, -C, -CR1', and -N(R12).beta.', where each .beta.' is 0 or 1, and each R1' is independently -L-R x; or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
each R12, when present (where .delta. or .beta.' is 1), is independently -L-R
x; or -L-S c; or is a C1-C22 alkyl or C7-C22 arylalkyl, each alkyl portion of which optionally incorporates up to six hetero atoms, selected from N, O and S, and each alkyl portion of which is optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, phosphate, amino, sulfate, phosphonate, cyano, nitro, azido, C1-C6 alkoxy, C1-alkylamino, C2-C12 dialkylamino, or C3-C18 trialkylammonium;
.delta. is 0 or 1, and .delta. + all .beta.' = 1;
Z is O, S, or CR13R14;
R13 and R14 are independently -L-R x ; or -L-S c ; or a C1-C22 alkyl or C7-C22 arylalkyl, each alkyl portion of which optionally incorporates up to six hetero atoms, selected from N, O and S, and each alkyl portion of which is optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, phosphate, amino, sulfate, phosphonate, cyano, nitro, azido, C1-C6 alkoxy, C1-C8 alkylamino, or C2-C12 dialkylamino, or C3-C18 trialkylammonium; or R13 and R14 taken in combination complete a five- or six-membered saturated or unsaturated ring that is optionally substituted by -L-R x; or -L-S c;
n is 1, 2 or 3; and each R21, R22, and R23 is independently H, F, Cl, C1-C6 alkyl, C1-C6 alkoxy, aryloxy, a nitrogen heterocycle, an iminium ion, -L-R x, or -L-S c; or any two adjacent substituents of R21, R22, R23, when taken in combination, forms a 4-, 5-, or 6-membered saturated or unsaturated hydrocarbon ring that is optionally substituted one or more times by C1-C6 alkyl, halogen, or a carbonyl oxygen; or R21 taken in combination with R4 forms a 6-membered ring that is optionally substituted by C1-C6 alkyl; or one of R23, whichever is adjacent to Z, taken in combination with one of R13 and R14 forms a 6-membered ring that is optionally substituted by C1-C6 alkyl.
2. A compound, as claimed in Claim 1, wherein the atoms of Y are selected from -CH, -C, and -CR1, where each R1 is independently -L-R x; or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C8 alkyl, C1-C8 alkoxy, C1-C6 alkylamino, dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
.alpha. is 1;
the atoms of W are selected from -CH, -C, -CR1', and -N(R12).beta.', where each .beta. is 0 or 1, and each R1' is independently -L-R x; or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
each R2 and R12 is independently -L-R x; or -L-S c; or a C1-C22 alkyl, which optionally incorporates up to six hetero atoms, and is optionally substituted;
.delta. is 0 or 1, and .delta. + all .beta.'= 1; and .delta. is 1 only if W
does not contain any ring nitrogen atoms;
Z is CR13R14.
.alpha. is 1;
the atoms of W are selected from -CH, -C, -CR1', and -N(R12).beta.', where each .beta. is 0 or 1, and each R1' is independently -L-R x; or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
each R2 and R12 is independently -L-R x; or -L-S c; or a C1-C22 alkyl, which optionally incorporates up to six hetero atoms, and is optionally substituted;
.delta. is 0 or 1, and .delta. + all .beta.'= 1; and .delta. is 1 only if W
does not contain any ring nitrogen atoms;
Z is CR13R14.
3. A compound, as claimed in Claim 2, wherein the atoms of W are selected from -CH, -C, -CR1', and -N(R12).beta.', where .beta.' is 1, but no more than one of the atoms in W is -N(R12).beta.', and each R1' is independently -L-R x; or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
and .delta. is 0.
and .delta. is 0.
4. A compound, as claimed in Claim 2, wherein the atoms of W are selected from -CH, -C, and -CR1', and each R1' is independently -L-R x; or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
.delta. is 1.
.delta. is 1.
5. A compound, as claimed in Claim 2, wherein R3 is -L-R x; or -L-S c; and R4 is independently a C1-C6 alkyl, which is optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, or amino;
the atoms of Y are selected from -CH, -C, and -CR1, where each R1 is independently -L-R x; or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
the atoms of W are selected from -CH, -C, -CR1', and -N(R12).beta.', where each .beta.' is 0 or 1, but no more than one of such atoms is -N(R12).beta.', and each R1' is independently -L-R x;
or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
R2 and R12 are independently -L-R x; or -L-S c; or is a C1-C6 alkyl, which is optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, or amino;
one of R13 and R14 is a C1-C6 alkyl and the other of R13 and R14 is -L-R x; or -L-S c ; or a C1-C22 alkyl, which is optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, phosphate, amino, sulfate, phosphonate, cyano, nitro, azido, alkoxy, C1-C6 alkylamino, or C2-C12 dialkylamino;
each of R21, R22, and R23 are H; or any two adjacent substituents of R21, R22, R23, when taken in combination, forms a 4-, 5-, or 6-membered saturated or unsaturated hydrocarbon ring that is optionally substituted one or more times by C1-C6 alkyl, halogen, or a carbonyl oxygen.
the atoms of Y are selected from -CH, -C, and -CR1, where each R1 is independently -L-R x; or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
the atoms of W are selected from -CH, -C, -CR1', and -N(R12).beta.', where each .beta.' is 0 or 1, but no more than one of such atoms is -N(R12).beta.', and each R1' is independently -L-R x;
or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
R2 and R12 are independently -L-R x; or -L-S c; or is a C1-C6 alkyl, which is optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, or amino;
one of R13 and R14 is a C1-C6 alkyl and the other of R13 and R14 is -L-R x; or -L-S c ; or a C1-C22 alkyl, which is optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, phosphate, amino, sulfate, phosphonate, cyano, nitro, azido, alkoxy, C1-C6 alkylamino, or C2-C12 dialkylamino;
each of R21, R22, and R23 are H; or any two adjacent substituents of R21, R22, R23, when taken in combination, forms a 4-, 5-, or 6-membered saturated or unsaturated hydrocarbon ring that is optionally substituted one or more times by C1-C6 alkyl, halogen, or a carbonyl oxygen.
6. A compound, as claimed in Claim 1, wherein R3 is -L-R x; and R4 is independently a C1-C22 alkyl, which optionally incorporates up to six hetero atoms, and is optionally substituted; or R3 and R4 taken in combination complete a five- or six-membered saturated or unsaturated ring that is substituted by -L-R x; and each R x is a reactive group that is independently an acrylamide, an activated ester of a carboxylic acid, an acyl azide, an acyl nitrile, an aldehyde, an alkyl halide, an anhydride, an aniline, an aryl halide, an azide, an aziridine, a boronate, a carboxylic acid, a diazoalkane, a haloacetamide, a halotriazine, a hydrazine (including hydrazides), an imido ester, an isocyanate, an isothiocyanate, a maleimide, a phosphoramidite, a reactive platinum complex, a sulfonyl halide, a thiol group, or a photoactivatable group;
no more than one of the atoms within Y is -N(R2).beta., and each R1 is independently -L-R x;
or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy; and each S c is a conjugated substance that is an amino acid, peptide, polypeptide, protein, nucleotide, oligonucleotide, nucleic acid polymer, a sugar, a polysaccharide, an oligosaccharide, a fluorescent dye, or a microsphere;
.alpha. is only 1 when Y contains no ring nitrogen atoms, no more than one of the atoms within W is -N(R12).beta.', and each R1' is independently -L--R x; or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
R2 and R12 are independently -L-R x; or -L-S c; or is a C1-C22 alkyl, which optionally incorporates up to six hetero atoms, and is optionally substituted;
.delta. is 1 only if W does not contain any ring nitrogen atoms;
Z is CR13R14;
R13 and R14 are independently -L-R x ; or -L-S c; or a C1-C22 alkyl, which optionally incorporates up to six hetero atoms, is optionally substituted;
or R13 and R14 taken in combination complete a five- or six-membered saturated or unsaturated ring that is optionally substituted by -L-R x; or -L-S c; and R21, R22, and R23 are independently H, F, Cl, C1-C6 alkyl, C1-C6 alkoxy, aryloxy, a nitrogen heterocycle, an iminium ion, -L-R x, or -L-S c.
no more than one of the atoms within Y is -N(R2).beta., and each R1 is independently -L-R x;
or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy; and each S c is a conjugated substance that is an amino acid, peptide, polypeptide, protein, nucleotide, oligonucleotide, nucleic acid polymer, a sugar, a polysaccharide, an oligosaccharide, a fluorescent dye, or a microsphere;
.alpha. is only 1 when Y contains no ring nitrogen atoms, no more than one of the atoms within W is -N(R12).beta.', and each R1' is independently -L--R x; or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
R2 and R12 are independently -L-R x; or -L-S c; or is a C1-C22 alkyl, which optionally incorporates up to six hetero atoms, and is optionally substituted;
.delta. is 1 only if W does not contain any ring nitrogen atoms;
Z is CR13R14;
R13 and R14 are independently -L-R x ; or -L-S c; or a C1-C22 alkyl, which optionally incorporates up to six hetero atoms, is optionally substituted;
or R13 and R14 taken in combination complete a five- or six-membered saturated or unsaturated ring that is optionally substituted by -L-R x; or -L-S c; and R21, R22, and R23 are independently H, F, Cl, C1-C6 alkyl, C1-C6 alkoxy, aryloxy, a nitrogen heterocycle, an iminium ion, -L-R x, or -L-S c.
7. A compound, as claimed in Claim 1, wherein R3 is -L-S c; and R4 is independently a C1-C22 alkyl, which optionally incorporates up to six hetero atoms, and is optionally substituted; or R3 and R4 taken in combination complete a five- or six-membered saturated or unsaturated ring that is substituted by -L-S c; and L is a single covalent bond, or a covalent linkage and S c is a conjugated substance that is an antibody, an amino acid, an angiostatin or endostatin, an avidin or streptavidin, a biotin, a blood component protein, a dextran, an enzyme, an enzyme inhibitor, a hormone, an IgG-binding protein, a fluorescent protein, a growth factor, a lectin, a lipopolysaccharide, a metal-binding protein, a microorganism or portion thereof, a neuropeptide, a non-biological microparticle, a nucleotide, an oligonucleotide, a peptide toxin, a phospholipid-binding protein, a small-molecule drug, a structural protein, or a tyramide;
no more than one of the atoms within Y is -N(R2).beta., and each R1 is independently -L-R x;
or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy; and -R x is a reactive group that is an activated ester of a carboxylic acid, an amine, a carboxylic acid, a halotriazine, a hydrazide, a maleimide, a reactive platinum complex; and a is only 1 when Y contains no ring nitrogen atoms, no more than one of the atoms within W is -N(R12).beta.', and each R1' is independently -L--R x; or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
R2 and R12 are independently -L-R x; or -L-S c; or is a C1-C22 alkyl, which optionally incorporates up to six hetero atoms, and is optionally substituted;
.delta. is 1 only if W does not contain any ring nitrogen atoms;
Z is CR13R14;
R13 and R14 are independently -L-R x; or -L-S c; or a C1-C22 alkyl, which optionally incorporates up to six hetero atoms, is optionally substituted;
or R13 and R14 taken in combination complete a five- or six-membered saturated or unsaturated ring that is optionally substituted by -L-R x; or -L-S c; and R21, R22, and R23, are independently H, F, Cl, C1-C6 alkyl, C1-C6 alkoxy, aryloxy, a nitrogen heterocycle, an iminium ion, -L-R x, or -L-S c.
no more than one of the atoms within Y is -N(R2).beta., and each R1 is independently -L-R x;
or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy; and -R x is a reactive group that is an activated ester of a carboxylic acid, an amine, a carboxylic acid, a halotriazine, a hydrazide, a maleimide, a reactive platinum complex; and a is only 1 when Y contains no ring nitrogen atoms, no more than one of the atoms within W is -N(R12).beta.', and each R1' is independently -L--R x; or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
R2 and R12 are independently -L-R x; or -L-S c; or is a C1-C22 alkyl, which optionally incorporates up to six hetero atoms, and is optionally substituted;
.delta. is 1 only if W does not contain any ring nitrogen atoms;
Z is CR13R14;
R13 and R14 are independently -L-R x; or -L-S c; or a C1-C22 alkyl, which optionally incorporates up to six hetero atoms, is optionally substituted;
or R13 and R14 taken in combination complete a five- or six-membered saturated or unsaturated ring that is optionally substituted by -L-R x; or -L-S c; and R21, R22, and R23, are independently H, F, Cl, C1-C6 alkyl, C1-C6 alkoxy, aryloxy, a nitrogen heterocycle, an iminium ion, -L-R x, or -L-S c.
8. A compound, as claimed in any of Claims 1-7, wherein L is a covalent linkage that is linear or branched, cyclic or heterocyclic, saturated or unsaturated, having 1-16 nonhydrogen atoms selected from the group consisting of C, N, P, O, and S, and incorporating the formula -(CH2)d(CONH(CH2)e)2'-, where d is 0-5, e is 1-5 and z' is 0 or 1, such that the linkage contains any combination of ether, thioether, amine, ester, amide bonds; or single, double, triple or aromatic carbon-carbon bonds; or phosphorus-oxygen, phosphorus-sulfur, nitrogen-nitrogen, nitrogen-oxygen, or nitrogen-platinum bonds; or aromatic or heteroaromatic bonds.
9. A compound, as claimed in any of Claims 1-8, wherein, R21, R22, and R23 are H.
10. A compound, as claimed in any of Claims 1-9, wherein S c is a conjugated substance that is an actin, an antibody or fragment thereof, an avidin or streptavidin, a biotin, a dextran, an enzyme, a fluorescent protein, a lectin, a lipopolysaccharide, a microorganism, a non-biological microparticle, a nucleotide, an oligonucleotide, a peptide toxin, a phosphotidylserine-binding protein, a protein A
or G, a small-molecule drug, or a tyramide.
or G, a small-molecule drug, or a tyramide.
11. A compound, as claimed in any of Claims 1-10, wherein the atoms of Y are selected from -CH, -C, and -CR1, where R1 is sulfo.
12. A compound, as claimed in any of Claims 1-3 and 5-11, wherein the atoms of W
are selected from -CH, -C, -CR1', and -N(R12).beta.', where each R1' is sulfo or Br.
are selected from -CH, -C, -CR1', and -N(R12).beta.', where each R1' is sulfo or Br.
13. A compound, as claimed in any of Claims 1-12, wherein R2 and R12 are independently a C1-C6 alkyl or C1-C6 alkyl substituted by sulfo.
14. A compound, as claimed in any of Claims 1-13, wherein, R13 and R14 are independently C1-C6 alkyl.
15. A compound of the formula and its salts, wherein R3 is -L-R x; or -L-S c; and R4 is a C1-C22 alkyl, and is optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, phosphate, amino, sulfate, phosphonate, cyano, nitro, azido, C1-C6 alkoxy, C1-C6 alkylamino, or C2-C12 dialkylamino, or C3-C18 trialkylammonium; or R3 and R4 taken in combination complete a five- or six-membered saturated or unsaturated ring that is substituted by -L-R x; or -L-S
c; and L is a single covalent bond, or a covalent linkage that is linear or branched, cyclic or heterocyclic, saturated or unsaturated, having 1-16 nonhydrogen atoms selected from the group consisting of C, N, P, O, and S, such that the linkage contains any combination of ether, thioether, amine, ester, amide bonds; or single, double, triple or aromatic carbon-carbon bonds; or phosphorus-oxygen, phosphorus-sulfur, nitrogen-nitrogen, nitrogen-oxygen, or nitrogen-platinum bonds; or aromatic or heteroaromatic bonds;
R x is a reactive group;
S c is a conjugated substance;
R6 through R9 and R16 through R18 are independently H, -L-R x; or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy; or any two adjacent substituents of R6 through R9 form a fused benzo ring that is optionally substituted one or more times by -L-R x; or by -L-S c; or by amino, sulfo, trifluoromethyl, or halogen; or by C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
R2 and R12 are independently a C1-C6 alkyl or C1-C6 alkyl substituted by sulfo;
R13 and R14 are independently a C1-C6 alkyl;
n is 1, 2 or 3.
c; and L is a single covalent bond, or a covalent linkage that is linear or branched, cyclic or heterocyclic, saturated or unsaturated, having 1-16 nonhydrogen atoms selected from the group consisting of C, N, P, O, and S, such that the linkage contains any combination of ether, thioether, amine, ester, amide bonds; or single, double, triple or aromatic carbon-carbon bonds; or phosphorus-oxygen, phosphorus-sulfur, nitrogen-nitrogen, nitrogen-oxygen, or nitrogen-platinum bonds; or aromatic or heteroaromatic bonds;
R x is a reactive group;
S c is a conjugated substance;
R6 through R9 and R16 through R18 are independently H, -L-R x; or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy; or any two adjacent substituents of R6 through R9 form a fused benzo ring that is optionally substituted one or more times by -L-R x; or by -L-S c; or by amino, sulfo, trifluoromethyl, or halogen; or by C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
R2 and R12 are independently a C1-C6 alkyl or C1-C6 alkyl substituted by sulfo;
R13 and R14 are independently a C1-C6 alkyl;
n is 1, 2 or 3.
16. A compound, as claimed in Claim 15, wherein R17 is H or Br, and R16 and R18 are H.
17. A compound of the formula and its salts, wherein R3 is -L-R x; or -L-S c; and R4 is a C1-C22 alkyl, and is optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, phosphate, amino, sulfate, phosphonate, cyano, nitro, azido, C1-C6 alkoxy, C1-C6 alkylamino, or C2-C12 dialkylamino, or C3-C18 trialkylammonium; or R3 and R4 taken in combination complete a five- or six-membered saturated or unsaturated ring that is substituted by -L-R x; or -L-S
c; and L is a single covalent bond, or a covalent linkage that is linear or branched, cyclic or heterocyclic, saturated or unsaturated, having 1-16 nonhydrogen atoms selected from the group consisting of C, N, P, O, and S, such that the linkage contains any combination of ether, thioether, amine, ester, amide bonds; or single, double, triple or aromatic carbon-carbon bonds; or phosphorus-oxygen, phosphorus-sulfur, nitrogen-nitrogen, nitrogen-oxygen, or nitrogen-platinum bonds; or aromatic or heteroaromatic bonds;
R x is a reactive group;
S c is a conjugated substance;
R6 through R9 and R16 through R19 are independently H, -L-R x; or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy; or any two adjacent substituents of R6 through R9 and R16 through form a fused benzo ring that is optionally substituted one or more times by -L-R x; or by -L-S c; or by amino, sulfo, trifluoromethyl, or halogen; or by C1-C6 alkyl, alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
R2 and R12 are independently a C1-C6 alkyl or C1-C6 alkyl substituted by sulfo;
R13 and R14 are independently a C1-C6 alkyl;
n is 1, 2 or 3.
c; and L is a single covalent bond, or a covalent linkage that is linear or branched, cyclic or heterocyclic, saturated or unsaturated, having 1-16 nonhydrogen atoms selected from the group consisting of C, N, P, O, and S, such that the linkage contains any combination of ether, thioether, amine, ester, amide bonds; or single, double, triple or aromatic carbon-carbon bonds; or phosphorus-oxygen, phosphorus-sulfur, nitrogen-nitrogen, nitrogen-oxygen, or nitrogen-platinum bonds; or aromatic or heteroaromatic bonds;
R x is a reactive group;
S c is a conjugated substance;
R6 through R9 and R16 through R19 are independently H, -L-R x; or -L-S c; or amino, sulfo, trifluoromethyl, or halogen; or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy; or any two adjacent substituents of R6 through R9 and R16 through form a fused benzo ring that is optionally substituted one or more times by -L-R x; or by -L-S c; or by amino, sulfo, trifluoromethyl, or halogen; or by C1-C6 alkyl, alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;
R2 and R12 are independently a C1-C6 alkyl or C1-C6 alkyl substituted by sulfo;
R13 and R14 are independently a C1-C6 alkyl;
n is 1, 2 or 3.
18. A compound, as claimed in Claim 17, wherein R17 is H, sulfo, or Br, and R16, R18, and R19 are H.
19. A compound, as claimed in any of Claims 15-18, wherein R7 is sulfo, and R6, R8, and R9 are H; or R6 and R7 combine to form a fused benzo ring that is substituted one or more times by sulfo, and R8 and R9 are H.
20. A compound, as claimed in any of Claims 1-19, wherein, L is a covalent linkage that incorporates the formula -(CH2)d(CONH(CH2)e)z,-, or -(CH2)d(CON(CH2)4NH(CH2)e)z,-, -(CH2)d(CONH(CH2)e NH2)z,-, -(CH2)d(CONH(CH2)e NHCO)-z,, where d is 0-5, e is 1-5 and z' is 0 or 1;
21. A compound, as claimed in any of Claims 1-20, wherein R4 is a C1-C6 alkyl.
22. A compound, as claimed in any of Claims 1-6 and 8-20, wherein there is only one R x on the compound and it is an activated ester of a carboxylic acid, an amine, a carboxylic acid, a halotriazine, a hydrazide, a maleimide, or a reactive platinum complex.
23. A compound, as claimed in any of Claims 1-22, where -L is -(CH2)d(CONH(CH2)e)z,-.
24. A compound, as claimed in any of Claims 1-23, wherein -Rx is a carboxylic acid, or a succinimidyl ester of a carboxylic acid, or a maleimide.
25. A compound, as claimed in any of Claims 1-4 and 6-21, wherein S c is a conjugated substance that is an antibody or fragment thereof, a fluorescent protein, a lectin, an oligonucleotide, a small-molecule drug, or a tyramide.
26. A compound, as claimed in any of Claims 1-25, where n=1.
27. A compound, as claimed in any of Claims 1-25, where n=2.
28. A compound, as claimed in any of Claims 1-25, where n=3.
29. A compound of the formula and its salts, wherein R3 is -L-R x or -L-S c; and R4, R13, and R14 are methyl;
L is a covalent linkage that is -(CH2)5(CONH(CH2)e)Z,-, e is 1-5 and z' is 0 or 1;
Rx is a reactive group that is a carboxylic acid, a succinimidyl ester of a carboxylic acid or a maleimide;
S c is a conjugated substance that is an antibody or fragment thereof, a fluorescent protein, a lectin, a nucleotide, an oligonucleotide, a peptide, a small-molecule drug, or a tyramide;
R2 and R12 are independently methyl or sulfopropyl;
R7 and R17 are sulfo, and R6, R8 , R9, R16, R18, and R19 are H; and n is 1.
L is a covalent linkage that is -(CH2)5(CONH(CH2)e)Z,-, e is 1-5 and z' is 0 or 1;
Rx is a reactive group that is a carboxylic acid, a succinimidyl ester of a carboxylic acid or a maleimide;
S c is a conjugated substance that is an antibody or fragment thereof, a fluorescent protein, a lectin, a nucleotide, an oligonucleotide, a peptide, a small-molecule drug, or a tyramide;
R2 and R12 are independently methyl or sulfopropyl;
R7 and R17 are sulfo, and R6, R8 , R9, R16, R18, and R19 are H; and n is 1.
30. A compound of the formula:
and its salts, wherein R3 is -L-R x or -L-Sc; and R4, R13, and R14 are methyl;
L is a covalent linkage that is -(CH2)5(CONH(CH2)e)Z; , e is 1-5 and z' is 0 or 1;
R x is a reactive group that is a carboxylic acid, a succinimidyl ester of a carboxylic acid or a maleimide;
S c is a conjugated substance that is an antibody or fragment thereof, a fluorescent protein, a lectin, a nucleotide, an oligonucleotide, a peptide, a small-molecule drug, or a tyramide;
R2 and Rl2 are independently methyl or sulfopropyl;
R7 and R17 are sulfo, and R6, R8 , R9, R16, R18, and R19 are H; and n is 2.
and its salts, wherein R3 is -L-R x or -L-Sc; and R4, R13, and R14 are methyl;
L is a covalent linkage that is -(CH2)5(CONH(CH2)e)Z; , e is 1-5 and z' is 0 or 1;
R x is a reactive group that is a carboxylic acid, a succinimidyl ester of a carboxylic acid or a maleimide;
S c is a conjugated substance that is an antibody or fragment thereof, a fluorescent protein, a lectin, a nucleotide, an oligonucleotide, a peptide, a small-molecule drug, or a tyramide;
R2 and Rl2 are independently methyl or sulfopropyl;
R7 and R17 are sulfo, and R6, R8 , R9, R16, R18, and R19 are H; and n is 2.
31. A compound of the formula:
and its salts, wherein R3 is -L-R I or -L-S c; and R4, R13, and R14 are methyl;
L is a covalent linkage that is -(CH2)5(CONH(CH2)e)Z'-, e is 1-5 and z' is 0 or 1;
R x is a reactive group that is a carboxylic acid, a succinimidyl ester of a carboxylic acid or a maleimide;
S c is a conjugated substance that is an antibody or fragment thereof, a fluorescent protein, a lectin, a nucleotide, an oligonucleotide, a peptide, a small-molecule drug, or a tyramide;
R2 and R12 are independently methyl or sulfopropyl;
R7 and R17 are sulfo, and R6, R8 , R9, R16, R18, and R19 are H;
n is 3.
and its salts, wherein R3 is -L-R I or -L-S c; and R4, R13, and R14 are methyl;
L is a covalent linkage that is -(CH2)5(CONH(CH2)e)Z'-, e is 1-5 and z' is 0 or 1;
R x is a reactive group that is a carboxylic acid, a succinimidyl ester of a carboxylic acid or a maleimide;
S c is a conjugated substance that is an antibody or fragment thereof, a fluorescent protein, a lectin, a nucleotide, an oligonucleotide, a peptide, a small-molecule drug, or a tyramide;
R2 and R12 are independently methyl or sulfopropyl;
R7 and R17 are sulfo, and R6, R8 , R9, R16, R18, and R19 are H;
n is 3.
32. A compound of the formula:
and its salts, wherein R3 is -L-R x or -L-S c; and R4, R13 and R14 are methyl;
L is a covalent linkage that is -(CH2)5(CONH(CH2)e)Z'-, e is 1-5 and z' is 0 or 1;
Rx is a reactive group that is a carboxylic acid, a succinimidyl ester of a carboxylic acid or a maleimide;
S c is a conjugated substance that is an antibody or fragment thereof, a fluorescent protein, a lectin, a nucleotide, an oligonucleotide, a peptide, a small-molecule drug, or a tyramide;
R6, R8, R9, R16, R17 and R18 are H; R7 is sulfopropyl;
R2 and R19 are independently methyl or sulfopropyl;
n is 2.
and its salts, wherein R3 is -L-R x or -L-S c; and R4, R13 and R14 are methyl;
L is a covalent linkage that is -(CH2)5(CONH(CH2)e)Z'-, e is 1-5 and z' is 0 or 1;
Rx is a reactive group that is a carboxylic acid, a succinimidyl ester of a carboxylic acid or a maleimide;
S c is a conjugated substance that is an antibody or fragment thereof, a fluorescent protein, a lectin, a nucleotide, an oligonucleotide, a peptide, a small-molecule drug, or a tyramide;
R6, R8, R9, R16, R17 and R18 are H; R7 is sulfopropyl;
R2 and R19 are independently methyl or sulfopropyl;
n is 2.
33. A compound of the formula:
and its salts, wherein R3 is -L-R x or -L-S c; and R4, R13 and R14 are methyl;
L is a covalent linkage that is -(CH2)5(CONH(CH2)e)Z'-, e is 1-5 and z' is 0 or 1;
R x is a reactive group that is a carboxylic acid, a succinimidyl ester of a carboxylic acid or a maleimide;
Sc is a conjugated substance that is an antibody or fragment thereof, a fluorescent protein, a lectin, a nucleotide, an oligonucleotide, a peptide, a small-molecule drug, or a tyramide;
R6, R8, R9, R16, and R18 are H; R7 is sulfo; R17 is Br;
R2 and R12 are independently methyl or sulfopropyl;
n is 2.
and its salts, wherein R3 is -L-R x or -L-S c; and R4, R13 and R14 are methyl;
L is a covalent linkage that is -(CH2)5(CONH(CH2)e)Z'-, e is 1-5 and z' is 0 or 1;
R x is a reactive group that is a carboxylic acid, a succinimidyl ester of a carboxylic acid or a maleimide;
Sc is a conjugated substance that is an antibody or fragment thereof, a fluorescent protein, a lectin, a nucleotide, an oligonucleotide, a peptide, a small-molecule drug, or a tyramide;
R6, R8, R9, R16, and R18 are H; R7 is sulfo; R17 is Br;
R2 and R12 are independently methyl or sulfopropyl;
n is 2.
34. A compound of the formula:
and its salts, wherein R3 is -L-R x or -L-S c; and R4, R13 and R14 are methyl;
L is a covalent linkage that is -(CH2)5(CONH(CH2)e)Z'-, e is 1-5 and z' is 0 or 1;
R X is a reactive group that is a carboxylic acid, a succinimidyl ester of a carboxylic acid or a maleimide;
S c is a conjugated substance that is an antibody or fragment thereof, a fluorescent protein, a lectin, a nucleotide, an oligonucleotide, a peptide, a small-molecule drug, or a tyramide;
R6 and R7 combine to form a fused benzo ring, which benzo ring is substituted meta and para to R7 attachment site by sulfo; R8, R9, R16, and R18 are H; R17 is Br;
R2 and R12 are independently methyl or sulfopropyl;
n is 2.
and its salts, wherein R3 is -L-R x or -L-S c; and R4, R13 and R14 are methyl;
L is a covalent linkage that is -(CH2)5(CONH(CH2)e)Z'-, e is 1-5 and z' is 0 or 1;
R X is a reactive group that is a carboxylic acid, a succinimidyl ester of a carboxylic acid or a maleimide;
S c is a conjugated substance that is an antibody or fragment thereof, a fluorescent protein, a lectin, a nucleotide, an oligonucleotide, a peptide, a small-molecule drug, or a tyramide;
R6 and R7 combine to form a fused benzo ring, which benzo ring is substituted meta and para to R7 attachment site by sulfo; R8, R9, R16, and R18 are H; R17 is Br;
R2 and R12 are independently methyl or sulfopropyl;
n is 2.
35. A method of staining a biological sample, comprising:
combining a dye solution comprising any of the dyes described in Claims l-34, with a biological sample in a concentration sufficient to yield a detectable optical response under the desired conditions.
combining a dye solution comprising any of the dyes described in Claims l-34, with a biological sample in a concentration sufficient to yield a detectable optical response under the desired conditions.
36. A method, as claimed in Claim 43, wherein the sample comprises cells.
37. A method, as claimed in Claim 43, wherein the sample comprises proteins or nucleic acid polymers in a microarray.
38. A method, as claimed in Claim 43, wherein the sample comprises a ligand that is a member of a specific binding pair, for which S c is a complementary member.
39. A method, as claimed in any of Claims 35-38, wherein the sample is contained in or on a solid or semi-solid matrix that is a membrane, an electrophoretic gel, a silicon chip, a glass slide, a microwell plate, or a microfluidic chip.
40. A kit for fluorescent labeling of a biological sample, comprising a dye solution comprising any of the compound described in Claims 1-34, or its salts;
and a buffer suitable for use with such sample.
and a buffer suitable for use with such sample.
41. A compound of the formula:
and its salts, wherein R3 is C3-C7 carboxyalkyl; and R4 is a C1-C6 alkyl;
R2 is H or a C1-C6 alkyl or C1-C6 alkyl substituted by sulfo.
R6 through R9 are independently H, amino, sulfo, trifluoromethyl, or halogen;
or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy; or any two adjacent substituents of R6 through R9 form a fused benzo ring that is optionally substituted one or more times by amino, sulfo, trifluoromethyl, or halogen; or by C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy.
and its salts, wherein R3 is C3-C7 carboxyalkyl; and R4 is a C1-C6 alkyl;
R2 is H or a C1-C6 alkyl or C1-C6 alkyl substituted by sulfo.
R6 through R9 are independently H, amino, sulfo, trifluoromethyl, or halogen;
or C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy; or any two adjacent substituents of R6 through R9 form a fused benzo ring that is optionally substituted one or more times by amino, sulfo, trifluoromethyl, or halogen; or by C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylamino, C2-C12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy.
42. A compound, as claimed in Claim 41, wherein R3 is C5-C6 carboxyalkyl; and R4 is methyl;
R2 is methyl or sulfopropyl;
R6 and R7 form a fused benzo ring that is optionally substituted one or more times by sulfo; or R7 is independently H or sulfo, and R6 is H; both R8 and R9 are H.
R2 is methyl or sulfopropyl;
R6 and R7 form a fused benzo ring that is optionally substituted one or more times by sulfo; or R7 is independently H or sulfo, and R6 is H; both R8 and R9 are H.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23663700P | 2000-09-29 | 2000-09-29 | |
US60/236,637 | 2000-09-29 | ||
US27687001P | 2001-03-16 | 2001-03-16 | |
US60/276,870 | 2001-03-16 | ||
PCT/US2001/030404 WO2002026891A1 (en) | 2000-09-29 | 2001-09-28 | Modified carbocyanine dyes and their conjugates |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2423806A1 true CA2423806A1 (en) | 2002-04-04 |
CA2423806C CA2423806C (en) | 2009-12-22 |
Family
ID=26929964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2423806 Expired - Lifetime CA2423806C (en) | 2000-09-29 | 2001-09-28 | Modified carbocyanine dyes and their conjugates |
Country Status (7)
Country | Link |
---|---|
US (15) | US6977305B2 (en) |
EP (2) | EP1322710B2 (en) |
AT (1) | ATE352586T2 (en) |
AU (1) | AU2001294859A1 (en) |
CA (1) | CA2423806C (en) |
DE (2) | DE60126297T2 (en) |
WO (1) | WO2002026891A1 (en) |
Families Citing this family (205)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6133445A (en) | 1997-12-17 | 2000-10-17 | Carnegie Mellon University | Rigidized trimethine cyanine dyes |
US20030030797A1 (en) * | 1999-09-24 | 2003-02-13 | Henry Palladino | Solid state fluorescence and absorption spectroscopy |
DE10046215B4 (en) * | 2000-09-19 | 2004-04-15 | Institut für Chemo- und Biosensorik Münster e.V. i.Ins. | Fluorochromes and their use |
DE60126297T2 (en) * | 2000-09-29 | 2007-11-15 | Molecular Probes, Inc., Eugene | MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES |
US7129346B2 (en) * | 2000-12-20 | 2006-10-31 | Molecular Probes, Inc. | Crown ether derivatives |
US7579463B2 (en) * | 2000-12-20 | 2009-08-25 | Life Technologies Corporation | Crown ether derivatives |
JP4676654B2 (en) * | 2001-07-19 | 2011-04-27 | 富士フイルム株式会社 | Fluorescent nucleotide and labeling method using the same |
US20050069962A1 (en) * | 2001-10-12 | 2005-03-31 | Archer Robert M | Antibody complexes and methods for immunolabeling |
US8323903B2 (en) * | 2001-10-12 | 2012-12-04 | Life Technologies Corporation | Antibody complexes and methods for immunolabeling |
US6972326B2 (en) * | 2001-12-03 | 2005-12-06 | Molecular Probes, Inc. | Labeling of immobilized proteins using dipyrrometheneboron difluoride dyes |
WO2003079015A1 (en) * | 2002-03-11 | 2003-09-25 | Visen Medical, Inc. | Optical imaging probes |
US7445894B2 (en) * | 2002-05-03 | 2008-11-04 | Molecular Probes, Inc. | Compositions and methods for detection and isolation of phosphorylated molecules |
US20040171034A1 (en) * | 2002-05-03 | 2004-09-02 | Brian Agnew | Compositions and methods for detection and isolation of phosphorylated molecules |
WO2004042347A2 (en) * | 2002-05-03 | 2004-05-21 | Molecular Probes, Inc. | Compositions and methods for detection and isolation of phosphorylated molecules |
US7615646B2 (en) | 2002-05-10 | 2009-11-10 | Carnegie Mellon University | Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups |
US7785898B2 (en) | 2002-05-31 | 2010-08-31 | Genetic Technologies Limited | Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood |
US7511155B2 (en) * | 2002-07-08 | 2009-03-31 | Ge Healthcare Uk Limited | Reagents and a method for saturation labelling of proteins |
AU2003270619A1 (en) | 2002-09-12 | 2004-04-30 | Molecular Probes, Inc. | Site-specific labeling of affinity tags in fusion proteins |
WO2004038038A2 (en) | 2002-10-23 | 2004-05-06 | University Of Utah Research Foundation | Amplicon melting analysis with saturation dyes |
US7005518B2 (en) * | 2002-10-25 | 2006-02-28 | Li-Cor, Inc. | Phthalocyanine dyes |
WO2004065491A1 (en) * | 2003-01-24 | 2004-08-05 | Schering Ag | Hydrophilic, thiol-reactive cyanine dyes and conjugates thereof with biomolecules for fluorescence diagnosis |
EP1599608A4 (en) | 2003-03-05 | 2007-07-18 | Genetic Technologies Ltd | Identification of fetal dna and fetal cell markers in maternal plasma or serum |
US7217649B2 (en) * | 2003-03-14 | 2007-05-15 | Lam Research Corporation | System and method for stress free conductor removal |
US7172907B2 (en) * | 2003-03-21 | 2007-02-06 | Ge Healthcare Bio-Sciences Corp. | Cyanine dye labelling reagents with meso-substitution |
JP4633716B2 (en) | 2003-05-20 | 2011-02-16 | インベスチゲン, インコーポレイテッド | System for detecting polynucleotides |
US7727969B2 (en) | 2003-06-06 | 2010-06-01 | Massachusetts Institute Of Technology | Controlled release nanoparticle having bound oligonucleotide for targeted delivery |
US7727752B2 (en) | 2003-07-29 | 2010-06-01 | Life Technologies Corporation | Kinase and phosphatase assays |
US7271265B2 (en) * | 2003-08-11 | 2007-09-18 | Invitrogen Corporation | Cyanine compounds and their application as quenching compounds |
EP1658499B1 (en) * | 2003-08-16 | 2007-10-03 | Bayer HealthCare AG | Determination of free fractions |
WO2005050206A2 (en) | 2003-09-17 | 2005-06-02 | Molecular Probes, Inc. | Competitive immunoassay |
US20050095174A1 (en) * | 2003-10-31 | 2005-05-05 | Wolf David E. | Semipermeable sensors for detecting analyte |
ES2372395T3 (en) | 2003-10-31 | 2012-01-19 | Ge Healthcare Limited | MARKING REAGENTS WITH CYANINE COLORS. |
US20050214807A1 (en) * | 2003-11-19 | 2005-09-29 | Iain Johnson | Environmental sensitive fluorogenic compounds and their application for singlet oxygen and protein detection |
EP1689764B1 (en) * | 2003-11-19 | 2013-01-02 | AlleLogic Biosciences Corporation | Oligonucleotides labeled with a plurality of fluorophores |
US7776529B2 (en) | 2003-12-05 | 2010-08-17 | Life Technologies Corporation | Methine-substituted cyanine dye compounds |
EP2607431B1 (en) | 2003-12-05 | 2016-08-24 | Life Technologies Corporation | Cyanine dye compounds |
WO2005071096A2 (en) | 2004-01-21 | 2005-08-04 | Molecular Probes, Inc. | Derivatives of cephalosporin and clavulanic acid for detecting beta-lacamase in a sample |
US7387887B2 (en) | 2004-04-20 | 2008-06-17 | University Of Utah Research Foundation | Nucleic acid melting analysis with saturation dyes |
US9657347B2 (en) | 2004-04-20 | 2017-05-23 | University of Utah Research Foundation and BioFire Defense, LLC | Nucleic acid melting analysis with saturation dyes |
US8961407B2 (en) | 2004-07-21 | 2015-02-24 | Covidien Lp | Surgical port assembly |
WO2006023231A2 (en) | 2004-07-27 | 2006-03-02 | Molecular Probes, Inc. | Fluorescent metal ion indicators with large stokes shift |
US7524672B2 (en) * | 2004-09-22 | 2009-04-28 | Sandia Corporation | Microfluidic microarray systems and methods thereof |
US7592139B2 (en) | 2004-09-24 | 2009-09-22 | Sandia National Laboratories | High temperature flow-through device for rapid solubilization and analysis |
US7572640B2 (en) * | 2004-09-28 | 2009-08-11 | Singulex, Inc. | Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties |
US9040305B2 (en) * | 2004-09-28 | 2015-05-26 | Singulex, Inc. | Method of analysis for determining a specific protein in blood samples using fluorescence spectrometry |
AU2005290314A1 (en) * | 2004-09-28 | 2006-04-06 | Singulex, Inc. | System and method for spectroscopic analysis of single particles |
US8685711B2 (en) | 2004-09-28 | 2014-04-01 | Singulex, Inc. | Methods and compositions for highly sensitive detection of molecules |
EP1794237A2 (en) | 2004-09-30 | 2007-06-13 | GE Healthcare UK Limited | Fluorescent nucleotide analogues |
WO2006047452A2 (en) * | 2004-10-25 | 2006-05-04 | Anaspec, Inc. | Reactive 1,3’-crosslinked carbocyanines and their bioconjugates |
WO2006099050A2 (en) * | 2005-03-09 | 2006-09-21 | Cepheid | Polar dyes |
US7456281B2 (en) | 2005-04-20 | 2008-11-25 | Idaho Technology, Inc. | Nucleic acid melting analysis with saturation dyes |
GB2425315B (en) * | 2005-04-22 | 2009-10-07 | Ge Healthcare Uk Ltd | Water-soluble fluoro-substituted cyanine dyes as reactive fluorescence labelling reagents |
US7598390B2 (en) * | 2005-05-11 | 2009-10-06 | Life Technologies Corporation | Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use |
US7737281B2 (en) * | 2005-05-24 | 2010-06-15 | Enzo Life Sciences, Inc. C/O Enzo Biochem, Inc. | Purine based fluorescent dyes |
US7569695B2 (en) * | 2005-05-24 | 2009-08-04 | Enzo Life Sciences, Inc. | Dyes for the detection or quantification of desirable target molecules |
US8227621B2 (en) * | 2005-06-30 | 2012-07-24 | Li-Cor, Inc. | Cyanine dyes and methods of use |
FR2889700B1 (en) * | 2005-08-11 | 2012-11-23 | Synthinnove Lab | MARKERS, METHOD FOR PRODUCING THE SAME, AND APPLICATIONS THEREOF |
US20070134685A1 (en) * | 2005-09-06 | 2007-06-14 | Invitrogen Corporation | Control of chemical modification |
PT1934607E (en) | 2005-10-13 | 2013-11-13 | Fundacao D Anna Sommer Champalimaud E Dr Carlos Montez Champalimaud | Multiplex in situ immunohistochemical analysis |
DE102006029454A1 (en) * | 2005-12-05 | 2007-06-06 | Dyomics Gmbh | Hydrophilic markers based on diastereomeric |
EP1792949B1 (en) * | 2005-12-05 | 2010-09-08 | Dyomics GmbH | Hydrophilic marker on the basis of diastereomeric cyanines |
US7521577B2 (en) | 2006-01-12 | 2009-04-21 | Molecular Probes, Inc. | Heavy metal binding compounds and their method of use |
US20070196860A1 (en) * | 2006-01-18 | 2007-08-23 | Invitrogen Corporation | Methods for Measuring Real Time Kinase Activity |
WO2007087582A1 (en) | 2006-01-24 | 2007-08-02 | Invitrogen Corporation | Device and methods for quantifying analytes |
WO2007090126A2 (en) * | 2006-01-30 | 2007-08-09 | Invitrogen Corporation | Compositions and methods for detecting and quantifying toxic substances in disease states |
US8114636B2 (en) | 2006-02-10 | 2012-02-14 | Life Technologies Corporation | Labeling and detection of nucleic acids |
EP2623986B1 (en) | 2006-02-10 | 2017-06-14 | Life Technologies Corporation | Labeling and detection of post translationally modified proteins |
US8562802B1 (en) | 2006-02-13 | 2013-10-22 | Life Technologies Corporation | Transilluminator base and scanner for imaging fluorescent gels, charging devices and portable electrophoresis systems |
US8021839B2 (en) * | 2006-02-24 | 2011-09-20 | Investigen, Inc. | Methods and compositions for detecting polynucleotides |
ATE515700T1 (en) | 2006-03-23 | 2011-07-15 | Absorber Ab | BLOOD GROUP ANTIGENS OF DIFFERENT TYPES FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
JP4958461B2 (en) * | 2006-03-30 | 2012-06-20 | 富士フイルム株式会社 | Near-infrared absorbing dye-containing curable composition |
ATE535525T1 (en) | 2006-03-31 | 2011-12-15 | Wako Pure Chem Ind Ltd | CYANINE DYE OF PYRAZOLE TYPE |
ES2550004T3 (en) | 2006-04-04 | 2015-11-03 | Singulex, Inc. | High sensitivity system and troponin analysis methods |
US7838250B1 (en) | 2006-04-04 | 2010-11-23 | Singulex, Inc. | Highly sensitive system and methods for analysis of troponin |
EP3156799B1 (en) | 2006-04-04 | 2024-01-24 | Novilux, LLC | Analyzer and method for highly sensitive detection of analytes |
US20070281363A1 (en) * | 2006-04-13 | 2007-12-06 | Ewald Terpetschnig | Luminescent compounds |
AU2007240316A1 (en) | 2006-04-20 | 2007-11-01 | Becton, Dickinson And Company | Thermostable proteins and methods of making and using thereof |
US20080076188A1 (en) * | 2006-06-19 | 2008-03-27 | Patsenker Leonid D | Luminescent compounds |
WO2008029085A2 (en) | 2006-09-06 | 2008-03-13 | Medical Research Council | Polymerase |
GB0619626D0 (en) * | 2006-10-05 | 2006-11-15 | Ge Healthcare Uk Ltd | Fluoro-substituted benzoxazole polymethine dyes |
WO2008076524A2 (en) | 2006-10-27 | 2008-06-26 | Life Technologies Corporation | Fluorogenic ph sensitive dyes and their method of use |
US7888506B2 (en) * | 2007-01-26 | 2011-02-15 | Duquesne University Of The Holy Spirit | Composition, synthesis, and use of a new class of fluorophores |
US8586743B2 (en) * | 2007-01-30 | 2013-11-19 | Life Technologies Corporation | Labeling reagents and methods of their use |
WO2008094637A2 (en) | 2007-01-30 | 2008-08-07 | Seta Biomedicals. Llc | Luminescent compounds |
JP5476989B2 (en) | 2007-01-31 | 2014-04-23 | 和光純薬工業株式会社 | Method for detecting amplification or deletion of genomic DNA fragment |
US8221721B2 (en) * | 2007-02-09 | 2012-07-17 | Visen Medical, Inc. | Polycyclo dyes and use thereof |
US7771947B2 (en) | 2007-02-23 | 2010-08-10 | Investigen, Inc. | Methods and compositions for rapid light-activated isolation and detection of analytes |
EP2116577A4 (en) * | 2007-02-28 | 2010-08-04 | Mitsubishi Kagaku Media Co Ltd | Cyanine dye and optical recording medium |
FR2913424B1 (en) | 2007-03-09 | 2009-07-24 | Cis Bio Internat Sa | CYANINE DERIVATIVES, FLUORESCENT CONJUGATES CONTAINING SAME AND USE THEREOF |
EP2157088A4 (en) * | 2007-04-11 | 2010-04-14 | Uchrezhdenie Rossiiskoi Akadem | Indicyanine dyes and the derivatives thereof for analysing biological micromolecules |
WO2008151089A2 (en) * | 2007-05-30 | 2008-12-11 | Invitrogen Corporation | Fluorescent phospholipase a2 indicators |
US20090087860A1 (en) * | 2007-08-24 | 2009-04-02 | Todd John A | Highly sensitive system and methods for analysis of prostate specific antigen (psa) |
EP2223086B2 (en) * | 2007-12-14 | 2016-06-01 | Biotium Inc. | Fluorescent compounds - labeling dyes |
WO2009117033A2 (en) | 2007-12-19 | 2009-09-24 | Singulex, Inc. | Scanning analyzer for single molecule detection and methods of use |
EP2269064B1 (en) | 2008-03-27 | 2016-11-30 | Promega Corporation | Protein labeling with cyanobenzothiazole conjugates |
WO2009140541A2 (en) | 2008-05-16 | 2009-11-19 | Life Technologies Corporation | Dual labeling methods for measuring cellular proliferation |
US7951959B2 (en) | 2008-09-17 | 2011-05-31 | Thermo Fisher Scientific (Milwaukee) LLC | Hydrophilic labels for biomolecules |
CN102272106A (en) * | 2008-11-07 | 2011-12-07 | 通用医疗公司 | Monofunctional carbocyanine dyes for in vivo and in vitro imaging |
JP2012509300A (en) * | 2008-11-20 | 2012-04-19 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | Dye conjugate imaging agent |
JP5500875B2 (en) | 2009-01-30 | 2014-05-21 | キヤノン株式会社 | Novel compound, probe using the novel compound, and contrast agent for fluorescence imaging using the novel compound or the probe |
CN102459469A (en) * | 2009-04-17 | 2012-05-16 | 利康股份有限公司 | Fluorescent imaging with substituted cyanine dyes |
EP2421955A4 (en) | 2009-04-21 | 2012-10-10 | Genetic Technologies Ltd | Methods for obtaining fetal genetic material |
WO2010138738A1 (en) | 2009-05-27 | 2010-12-02 | Lumicell Diagnostics, Inc. | Methods and systems for spatially identifying abnormal cells |
US9155471B2 (en) | 2009-05-27 | 2015-10-13 | Lumicell, Inc'. | Methods and systems for spatially identifying abnormal cells |
AU2010259022B2 (en) | 2009-06-08 | 2016-05-12 | Singulex, Inc. | Highly sensitive biomarker panels |
US8309059B2 (en) | 2009-08-31 | 2012-11-13 | Promega Corporation | Reactive cyanine compounds |
US8652441B2 (en) * | 2009-10-05 | 2014-02-18 | Canon Kabushiki Kaisha | Contrast agent for photoacoustic imaging and photoacoustic imaging method |
US8658434B2 (en) * | 2009-10-28 | 2014-02-25 | Biotium, Inc. | Fluorescent pyrene compounds |
US9579402B2 (en) * | 2009-12-04 | 2017-02-28 | Biotium, Inc. | Heterocycle-substituted xanthene dyes |
US8974651B2 (en) | 2010-04-17 | 2015-03-10 | C.C. Imex | Illuminator for visualization of fluorophores |
WO2011140484A1 (en) | 2010-05-06 | 2011-11-10 | Singulex, Inc | Methods for diagnosing, staging, predicting risk for developing and identifying treatment responders for rheumatoid arthritis |
CN103052690A (en) * | 2010-06-29 | 2013-04-17 | 通用电气医疗集团股份有限公司 | Dye compositions and dye syntheses |
GB201010878D0 (en) * | 2010-06-29 | 2010-08-11 | Ge Healthcare As | Dye compositiion and dye syntheses |
US8623324B2 (en) | 2010-07-21 | 2014-01-07 | Aat Bioquest Inc. | Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates |
WO2012022734A2 (en) | 2010-08-16 | 2012-02-23 | Medimmune Limited | Anti-icam-1 antibodies and methods of use |
WO2012054749A1 (en) | 2010-10-20 | 2012-04-26 | Li-Cor, Inc. | Cyanine dyes and their conjugates |
US20130287689A1 (en) * | 2010-11-02 | 2013-10-31 | Life Technologies Corporation | Modified Hydrocyanine Dyes for the Detection of Reactive Oxygen Species |
US9314304B2 (en) | 2010-12-08 | 2016-04-19 | Lumicell, Inc. | Methods and system for image guided cell ablation with microscopic resolution |
EP3029027B1 (en) | 2010-12-21 | 2018-06-27 | Pierce Biotechnology, Inc. | Fluorescent compounds |
US8889884B1 (en) | 2011-07-14 | 2014-11-18 | Pierce Biotechnology, Inc. | Phosphine derivatives of fluorescent compounds |
US9249307B2 (en) | 2011-08-16 | 2016-02-02 | Pierce Biotechnology, Inc. | Benzocyanine compounds |
WO2013039883A1 (en) | 2011-09-12 | 2013-03-21 | Abbvie Biotherapeutics Inc. | Artificial nk cells and uses thereof |
EP2758475B1 (en) | 2011-09-23 | 2017-04-26 | Illumina Cambridge Limited | Dyes for labelling molecular ligands |
CZ304094B6 (en) * | 2011-12-01 | 2013-10-16 | Vysoká skola chemicko-technologická v Praze | Use of polymethine salts as mitochondrial probes |
NL2008241C2 (en) * | 2012-02-06 | 2013-08-08 | Hq Medical Netherlands B V | Cell death probe. |
US9751868B2 (en) | 2012-02-28 | 2017-09-05 | Pierce Biotechnology, Inc. | Benzocyanine compounds |
US20140072515A9 (en) | 2012-03-02 | 2014-03-13 | Greg Hermanson | Cyanine compounds |
CA2867144C (en) | 2012-03-27 | 2019-07-02 | Ventana Medical Systems, Inc. | Signaling conjugates and methods of use |
WO2013181506A1 (en) | 2012-05-31 | 2013-12-05 | The University Of North Carolina At Chapel Hill | Dissolution guided wetting of structured surfaces |
CN104540819B (en) | 2012-08-28 | 2019-04-19 | 皮尔斯生物科技有限公司 | Benzopyran compounds |
BR112015003160A2 (en) * | 2012-10-24 | 2017-07-04 | Becton Dickinson Co | hydroxamate-substituted bioconjugated azaindoline - cyanine dyes thereof |
EP2912459A2 (en) | 2012-10-25 | 2015-09-02 | Life Technologies Corporation | Methods and compositions for enzyme-mediated site-specific radiolabeling of glycoproteins |
US20160010145A1 (en) * | 2012-12-07 | 2016-01-14 | Life Technologies Corporation | Detection of rna with substituted unsymmetrical cyanine dyes |
DK2964624T3 (en) | 2013-03-08 | 2017-04-03 | Illumina Cambridge Ltd | RHODAMINE COMPOUNDS AND USE AS FLUORESCING LABELS |
AU2013380645B2 (en) | 2013-03-08 | 2018-03-15 | Illumina Cambridge Ltd | Polymethine compounds and their use as fluorescent labels |
KR20160037834A (en) | 2013-03-14 | 2016-04-06 | 루미셀, 아이엔씨. | Medical imaging device and methods of use |
EP2970674B1 (en) | 2013-03-15 | 2018-12-12 | VisEn Medical, Inc. | 4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof |
CA2901379C (en) | 2013-03-15 | 2023-05-16 | Visen Medical, Inc. | Substituted silaxanthenium red to near-infrared fluorochromes for in vitro and in vivo imaging and detection |
US10024863B2 (en) | 2013-03-15 | 2018-07-17 | Life Technologies Corporation | Methods for dye selection for protein melt temperature determinations |
WO2015050959A1 (en) | 2013-10-01 | 2015-04-09 | Yale University | Anti-kit antibodies and methods of use thereof |
BR112016006999B1 (en) | 2013-10-02 | 2023-11-14 | Medimmune, Llc | ANTI-INFLUENZA NEUTRALIZING ANTIBODIES AND THEIR USES, THEIR PRODUCTION METHOD, COMPOSITION THAT COMPRISES THEM, NUCLEIC ACID AND VECTOR |
US9636034B2 (en) | 2013-10-23 | 2017-05-02 | Verily Life Sciences Llc | Non-invasive analyte detection system with modulation source |
US10542918B2 (en) | 2013-10-23 | 2020-01-28 | Verily Life Sciences Llc | Modulation of a response signal to distinguish between analyte and background signals |
US9835587B2 (en) | 2014-04-01 | 2017-12-05 | C.C. Imex | Electrophoresis running tank assembly |
GB201408077D0 (en) | 2014-05-07 | 2014-06-18 | Illumina Cambridge Ltd | Polymethine compounds and their use as fluorescent labels |
EP2944326B1 (en) * | 2014-05-16 | 2018-11-21 | Cyanagen Srl | Tricarbocyanine-cyclodextrin-conjugates and their use for the diagnosis of kidney diseases |
US10357510B2 (en) * | 2014-08-07 | 2019-07-23 | The Regents Of The University Of Michigan | Metal nanoclusters and uses thereof |
UA109751C2 (en) | 2014-09-26 | 2015-09-25 | METHOD OF DETERMINATION OF HYDROGEL IN BIOLOGICAL FABRICS | |
SG10202012249YA (en) | 2014-12-08 | 2021-01-28 | Berg Llc | Use of markers including filamin a in the diagnosis and treatment of prostate cancer |
US9861710B1 (en) | 2015-01-16 | 2018-01-09 | Verily Life Sciences Llc | Composite particles, methods, and in vivo diagnostic system |
JP6552236B2 (en) * | 2015-03-23 | 2019-07-31 | キヤノン株式会社 | Near-infrared dye-bound transferrin, contrast agent for photoacoustic imaging comprising the near-infrared dye-bound transferrin |
US10028659B2 (en) | 2015-03-26 | 2018-07-24 | Verily Life Sciences Llc | Aptamer-based sensors, implantable devices and detection system |
GB201508858D0 (en) | 2015-05-22 | 2015-07-01 | Illumina Cambridge Ltd | Polymethine compounds with long stokes shifts and their use as fluorescent labels |
EP3098269B1 (en) | 2015-05-28 | 2022-04-06 | Miltenyi Biotec B.V. & Co. KG | Bright fluorochromes based on multimerization of fluorescent dyes on branched polyether scaffolds |
US9670318B2 (en) | 2015-05-28 | 2017-06-06 | Miltenyi Biotec Gmbh | Bright fluorochromes based on multimerization of fluorescent dyes |
GB201516987D0 (en) | 2015-09-25 | 2015-11-11 | Illumina Cambridge Ltd | Polymethine compounds and their use as fluorescent labels |
CN112274649A (en) * | 2015-12-10 | 2021-01-29 | 希望之城 | Cell penetrating cyanine conjugated antibodies |
US9862682B2 (en) | 2016-01-08 | 2018-01-09 | BroadPharm | Functionalized pegylated cyanine compounds, pharmaceutical compositions, and methods of use thereof |
ES2936226T3 (en) | 2016-04-15 | 2023-03-15 | Beckman Coulter Inc | Photoactive macromolecules and their uses |
US20190120845A1 (en) | 2016-04-15 | 2019-04-25 | Icahn School Of Medicine At Mount Sinai | Tissue profiling using multiplexed immunohistochemical consecutive staining |
US10294204B2 (en) * | 2016-04-27 | 2019-05-21 | Bioacts Co., Ltd. | Fluorescence compounds and preparation method thereof |
KR101944912B1 (en) * | 2016-04-27 | 2019-02-07 | (주)바이오액츠 | Fluorescence Compounds and Preparation Method Therof |
US9796854B1 (en) | 2016-07-07 | 2017-10-24 | Intuitive Surgical Operations, Inc. | Method of synthesizing near IR, closed chain sulfo-cyanine dyes |
CN110546273A (en) | 2017-03-30 | 2019-12-06 | 生命技术公司 | quantification of NGS DNA by adaptor sequences |
GB201711219D0 (en) | 2017-07-12 | 2017-08-23 | Illumina Cambridge Ltd | Short pendant arm linkers for nucleotides in sequencing applications |
CN107290198B (en) * | 2017-07-25 | 2019-07-16 | 中国科学院微生物研究所 | A method of biomaterial is dyed using PIP |
US11091646B2 (en) | 2017-08-14 | 2021-08-17 | Seta Biomedicals, Llc | Luminescent squaraine rotaxane compounds |
GB201716931D0 (en) | 2017-10-16 | 2017-11-29 | Illumina Cambridge Ltd | New fluorescent compounds and their use as biomarkers |
WO2019204432A2 (en) * | 2018-04-17 | 2019-10-24 | Cornell University | Fluorine-18 labeled compositions and their use in imaging of biological tissue |
CN108752406A (en) * | 2018-05-29 | 2018-11-06 | 苏州百源基因技术有限公司 | A kind of nucleotide of fluorescent marker and its preparation method and application |
US11408840B2 (en) | 2018-06-28 | 2022-08-09 | Just-Evotec Biologics, Inc. | High throughput interrogation of physiochemical properties of a protein |
BR102019025989A2 (en) | 2018-12-14 | 2020-06-23 | Beckman Coulter, Inc. | MODIFICATION OF POLYMERIC DYES AND APPLICATIONS |
BR112020026669A2 (en) | 2019-03-01 | 2021-09-08 | Illumina Cambridge Limited | COUMARIN COMPOUND SUBSTITUTED WITH TERTIARY AMINE, NUCLEOTIDES OR OLIGONUCLEOTIDES, KIT, USE THEREOF, SEQUENCING METHOD AND METHOD TO SYNTHESIS A COMPOUND |
CA3103900A1 (en) | 2019-03-01 | 2020-09-10 | Illumina Cambridge Limited | Exocyclic amine substituted coumarin compounds and their uses as fluorescent labels |
WO2020178231A1 (en) | 2019-03-01 | 2020-09-10 | Illumina, Inc. | Multiplexed fluorescent detection of analytes |
NL2023327B1 (en) | 2019-03-01 | 2020-09-17 | Illumina Inc | Multiplexed fluorescent detection of analytes |
KR20220015394A (en) | 2019-04-30 | 2022-02-08 | 라리마 테라퓨틱스, 인코포레이티드 | Frataxin sensitivity markers for determining the efficacy of prataxin replacement therapy |
WO2021096971A1 (en) * | 2019-11-11 | 2021-05-20 | The Trustees Of Dartmouth College | Composition and method for in vivo assay of opioid receptors |
CN111393872B (en) * | 2020-03-18 | 2022-05-17 | 宝天生物科技(上海)有限公司 | Ultraviolet light excited fluorescent dye and application thereof |
CN115397923A (en) * | 2020-04-24 | 2022-11-25 | 富士胶片株式会社 | Compound and labeled biological substance using same |
KR20230034333A (en) | 2020-07-02 | 2023-03-09 | 라이프 테크놀로지스 코포레이션 | Trinucleotide Cap Analogues, Preparation and Uses Thereof |
CN116323965A (en) | 2020-07-23 | 2023-06-23 | 生命技术公司 | Compositions, systems and methods for bioassays using dyes |
CN116075597A (en) | 2020-07-23 | 2023-05-05 | 生命技术公司 | Energy transfer dye conjugates for use in bioassays |
US20220033900A1 (en) | 2020-07-28 | 2022-02-03 | Illumina Cambridge Limited | Substituted coumarin dyes and uses as fluorescent labels |
EP4190795A1 (en) | 2020-07-30 | 2023-06-07 | FUJIFILM Corporation | Compound, and labeled biological substance in which same is used |
WO2022047359A1 (en) | 2020-08-31 | 2022-03-03 | Berg Llc | Protein biomarkers for pancreatic cancer |
CN117015711A (en) | 2021-02-05 | 2023-11-07 | 贝克曼库尔特有限公司 | Compositions and methods for preventing non-specific interactions between polymer dye-antibody conjugates |
US20230059578A1 (en) | 2021-04-06 | 2023-02-23 | Berg Llc | Protein markers for estrogen receptor (er)-positive-like and estrogen receptor (er)-negative-like breast cancer |
EP4320440A1 (en) | 2021-04-06 | 2024-02-14 | BPGbio, Inc. | Protein markers for estrogen receptor (er)-positive luminal a(la)-like and luminal b1 (lb1)-like breast cancer |
CA3214833A1 (en) | 2021-04-06 | 2022-10-13 | Bpgbio, Inc. | Protein markers for the prognosis of breast cancer progression |
WO2022265043A1 (en) | 2021-06-18 | 2022-12-22 | 富士フイルム株式会社 | Compound and labeled biomaterial using same |
CN117529529A (en) * | 2021-07-21 | 2024-02-06 | 生命技术公司 | Azaindole cyanine dye, application and preparation method |
WO2023004400A1 (en) | 2021-07-21 | 2023-01-26 | Life Technologies Corporation | Dibenzoxanthene quenchers, uses, and methods of preparation |
CN117460790A (en) | 2021-08-18 | 2024-01-26 | 富士胶片株式会社 | Fluorescent compound and fluorescent-labeled biological material using same |
WO2023032994A1 (en) | 2021-08-31 | 2023-03-09 | 富士フイルム株式会社 | Compound and labeled biomaterial using same |
WO2023032996A1 (en) | 2021-08-31 | 2023-03-09 | 富士フイルム株式会社 | Compound and labeled biomaterial using same |
WO2023032995A1 (en) | 2021-08-31 | 2023-03-09 | 富士フイルム株式会社 | Compound and labeled biomaterial using same |
WO2023056460A1 (en) | 2021-09-30 | 2023-04-06 | Beckman Coulter, Inc. | Water-soluble tetrahydropyrene based fluorescent polymers |
WO2023086103A1 (en) | 2021-11-12 | 2023-05-19 | Beckman Coulter, Inc. | Novel formulation for drying of polymer dye conjugated antibodies |
KR102414574B1 (en) * | 2022-02-27 | 2022-06-30 | (주)바이오액츠 | Fluorescent compound for detecting biological materials and the preparation method thereof |
US20230357851A1 (en) | 2022-04-06 | 2023-11-09 | Larimar Therapeutics, Inc. | Frataxin-sensitive markers for monitoring frataxin-replacement therapy |
WO2023240201A1 (en) | 2022-06-08 | 2023-12-14 | Larimar Therapeutics, Inc. | Frataxin-sensitive markers for monitoring progression and treatment of leigh syndrome |
WO2024007016A2 (en) | 2022-07-01 | 2024-01-04 | Beckman Coulter, Inc. | Novel fluorescent dyes and polymers from dihydrophenanthrene derivatives |
WO2024044327A1 (en) | 2022-08-26 | 2024-02-29 | Beckman Coulter, Inc. | Dhnt monomers and polymer dyes with modified photophysical properties |
CN115772390B (en) * | 2022-12-02 | 2023-09-08 | 湖北龙海化工有限公司 | Low-fluorescence blocking anti-collapse asphalt for drilling fluid |
Family Cites Families (97)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB870753A (en) | 1957-07-04 | 1961-06-21 | Ilford Ltd | Improvements in or relating to methine dyes |
US2993791A (en) | 1957-10-31 | 1961-07-25 | Gen Aniline & Film Corp | Color couplers containing long chain alkylaminoisophthalicester groups |
US3723419A (en) | 1967-05-17 | 1973-03-27 | Eastman Kodak Co | Preparation of formylmethylene compounds and corresponding photographic dyestuffs |
US3864644A (en) | 1971-03-22 | 1975-02-04 | Eastman Kodak Co | Dye lasers including rigidized carbocyanine dyes |
US4011086A (en) | 1975-10-14 | 1977-03-08 | Eastman Kodak Company | Photographic emulsions and elements containing rigidized carbocyanine dyes |
US4273862A (en) | 1977-06-11 | 1981-06-16 | Mitsubishi Paper Mills, Ltd. | Direct-positive silver halide photographic sensitive materials |
US4711955A (en) | 1981-04-17 | 1987-12-08 | Yale University | Modified nucleotides and methods of preparing and using same |
US5171534A (en) | 1984-01-16 | 1992-12-15 | California Institute Of Technology | Automated DNA sequencing technique |
US6086737A (en) | 1984-03-29 | 2000-07-11 | Li-Cor, Inc. | Sequencing near infrared and infrared fluorescence labeled DNA for detecting using laser diodes and suitable labels therefor |
US5366603A (en) | 1984-03-29 | 1994-11-22 | Li-Cor, Inc. | Sequencing near infrared and infrared fluorescence labeled DNA for detecting useing laser diodes |
JPS62123454A (en) † | 1985-08-08 | 1987-06-04 | Fuji Photo Film Co Ltd | Silver halide photographic sensitive material |
US5627027A (en) | 1986-04-18 | 1997-05-06 | Carnegie Mellon University | Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods |
US6048982A (en) * | 1986-04-18 | 2000-04-11 | Carnegie Mellon University | Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods |
US5268486A (en) * | 1986-04-18 | 1993-12-07 | Carnegie-Mellon Unversity | Method for labeling and detecting materials employing arylsulfonate cyanine dyes |
US6225050B1 (en) * | 1986-04-18 | 2001-05-01 | Carnegie Mellon University | Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods |
US5569587A (en) | 1986-04-18 | 1996-10-29 | Carnegie Mellon University | Method for labeling and detecting materials employing luminescent arysulfonate cyanine dyes |
US5047519A (en) | 1986-07-02 | 1991-09-10 | E. I. Du Pont De Nemours And Company | Alkynylamino-nucleotides |
CA1340806C (en) | 1986-07-02 | 1999-11-02 | James Merrill Prober | Method, system and reagents for dna sequencing |
US5049673A (en) | 1987-10-30 | 1991-09-17 | The Regents Of The University Of California | Fluorescent indicator dyes for calcium working at long wavelengths |
JPH0672706B2 (en) | 1988-05-31 | 1994-09-14 | 清水建設株式会社 | Scent supply method and scent supply device |
US4997928A (en) | 1988-09-15 | 1991-03-05 | E. I. Du Pont De Nemours And Company | Fluorescent reagents for the preparation of 5'-tagged oligonucleotides |
US5196306A (en) | 1989-03-29 | 1993-03-23 | E. I. Du Pont De Nemours And Company | Method for the detection or quantitation of an analyte using an analyte dependent enzyme activation system |
US5137810A (en) | 1989-04-26 | 1992-08-11 | The University Of North Carolina | Method of determining the gram sign of bacteria |
US4981977A (en) | 1989-06-09 | 1991-01-01 | Carnegie-Mellon University | Intermediate for and fluorescent cyanine dyes containing carboxylic acid groups |
JPH0614984Y2 (en) | 1989-11-29 | 1994-04-20 | 西川化成株式会社 | Parts mounting structure to resin molding |
US5405975A (en) | 1993-03-29 | 1995-04-11 | Molecular Probes, Inc. | Fluorescent ion-selective diaryldiaza crown ether conjugates |
US5648270A (en) | 1995-02-06 | 1997-07-15 | Molecular Probes, Inc. | Methods of sensing with fluorescent conjugates of metal-chelating nitrogen heterocycles |
US5453517A (en) | 1992-02-25 | 1995-09-26 | Molecular Probes, Inc. | Reactive derivatives of bapta used to make ion-selective chelators |
US5567588A (en) | 1990-06-11 | 1996-10-22 | University Research Corporation | Systematic evolution of ligands by exponential enrichment: Solution SELEX |
FR2664760B1 (en) * | 1990-07-13 | 1996-09-27 | Sgs Thomson Microelectronics | DEVICE FOR PROTECTION AGAINST OVERVOLTAGES AND ITS MONOLITHIC IMPLEMENTATION. |
NL9001639A (en) | 1990-07-19 | 1992-02-17 | Amc Amsterdam | PT-CONTAINING COMPOUND, METHOD FOR PREPARING IT, AND USE OF SUCH COMPOUNDS. |
US5714327A (en) | 1990-07-19 | 1998-02-03 | Kreatech Diagnostics | Platinum-containing compounds, methods for their preparation and applications thereof |
US5208148A (en) | 1990-12-07 | 1993-05-04 | Molecular Probes, Inc. | Lipophilic fluorescent glycosidase substrates |
YU187991A (en) | 1990-12-11 | 1994-09-09 | Hoechst Aktiengesellschaft | 3- (2) -AMINO-ALI THIOL-MODIFIED, FLUORESCENT-DYED NUCLEOSIDES, NUCLEOTIDS AND OLIGONUCLEOTIDES, PROCESS FOR THEIR OBTAINING AND THEIR USE |
JPH08168B2 (en) | 1991-02-12 | 1996-01-10 | マルチネツ ムジカ デー.フェルナンド | Filtration device for machine tools |
JP3084454B2 (en) | 1991-04-23 | 2000-09-04 | コニカ株式会社 | Silver halide photographic material |
US5539082A (en) | 1993-04-26 | 1996-07-23 | Nielsen; Peter E. | Peptide nucleic acids |
SE9200917D0 (en) * | 1991-08-20 | 1992-03-25 | Pharmacia Biosensor Ab | ASSAY METHOD |
US5831098A (en) | 1992-03-16 | 1998-11-03 | Minnesota Mining And Manufacturing Company | 2-methyl-4,4a-dihydro-3H-carbazolium salts and dyes derived therefrom |
JPH05313304A (en) † | 1992-05-11 | 1993-11-26 | Fuji Photo Film Co Ltd | Silver halide photographic sensitive material |
JPH0614984A (en) | 1992-07-01 | 1994-01-25 | Yamatake Honeywell Co Ltd | Scent generating device |
EP0658167B1 (en) | 1992-09-03 | 1999-04-14 | The Perkin-Elmer Corporation | 4,7-dichlorofluorescein dyes as molecular probes |
US5808044A (en) | 1993-01-22 | 1998-09-15 | Pharmacia Biotech Inc. | Indocarbocyanine and benzindocarbocyanine phosphoramidites |
US5556959A (en) | 1993-01-22 | 1996-09-17 | Pharmacia P-L Biochemicals Inc. | Indocarbocyanine-linked phosphoramidites |
US5436134A (en) | 1993-04-13 | 1995-07-25 | Molecular Probes, Inc. | Cyclic-substituted unsymmetrical cyanine dyes |
US5496700A (en) * | 1993-08-06 | 1996-03-05 | The United States Of America As Represented By The Secretary Of The Navy | Optical immunoassay for microbial analytes using non-specific dyes |
US5516911A (en) | 1993-12-30 | 1996-05-14 | The United States Of America As Represented By The Department Of Health And Human Services | Fluorescent intracellular calcium indicators |
US5453505A (en) | 1994-06-30 | 1995-09-26 | Biometric Imaging, Inc. | N-heteroaromatic ion and iminium ion substituted cyanine dyes for use as fluorescence labels |
US5487502A (en) | 1994-07-25 | 1996-01-30 | Liao; Ming-Kang | Decorative means for emitting odor and generating sound |
DE69526617T2 (en) * | 1994-09-22 | 2002-08-29 | Fuji Photo Film Co Ltd | Infrared absorbing dye Silver halide photographic material |
US5547588A (en) * | 1994-10-25 | 1996-08-20 | Gas Research Institute | Enhanced ettringite formation for the treatment of hazardous liquid waste |
US6150510A (en) | 1995-11-06 | 2000-11-21 | Aventis Pharma Deutschland Gmbh | Modified oligonucleotides, their preparation and their use |
DE4445065A1 (en) | 1994-12-07 | 1996-06-13 | Diagnostikforschung Inst | Methods for in-vivo diagnostics using NIR radiation |
US6127134A (en) | 1995-04-20 | 2000-10-03 | Carnegie Mellon University | Difference gel electrophoresis using matched multiple dyes |
US5684142A (en) | 1995-06-07 | 1997-11-04 | Oncor, Inc. | Modified nucleotides for nucleic acid labeling |
US6008373A (en) | 1995-06-07 | 1999-12-28 | Carnegie Mellon University | Fluorescent labeling complexes with large stokes shift formed by coupling together cyanine and other fluorochromes capable of resonance energy transfer |
JP3292007B2 (en) * | 1995-11-09 | 2002-06-17 | 松下電器産業株式会社 | Dye-labeled protein complex and method for producing the same |
US6004536A (en) | 1995-11-14 | 1999-12-21 | Molecular Probes, Inc. | Lipophilic cyanine dyes with enchanced aqueous solubilty |
US5668268A (en) | 1995-11-27 | 1997-09-16 | Hybridon, Inc. | Passivated polymer supports for nucleic acid synthesis |
US6165734A (en) * | 1995-12-12 | 2000-12-26 | Applied Spectral Imaging Ltd. | In-situ method of analyzing cells |
US5714386A (en) | 1996-01-11 | 1998-02-03 | Board Of Trustees Of The Leland Stanford Junior University | Cy7-allophycocyanin conjugates for use in multiplex fluorescence detection assays |
US5922618A (en) * | 1996-03-04 | 1999-07-13 | Matsushita Electric Industrial Co., Ltd. | Dye-labeled antibody conjugate and preparation method thereof |
DE69706417T2 (en) | 1996-04-19 | 2002-06-27 | Amersham Pharm Biotech Uk Ltd | SQUARE DYES AND THEIR USE IN A FLUORESCENCE SEQUENCING PROCESS |
US6245499B1 (en) * | 1996-04-30 | 2001-06-12 | Fuji Photo Film Co., Ltd. | Photothermographic material |
JP3537267B2 (en) * | 1996-06-06 | 2004-06-14 | 松下電器産業株式会社 | Equipment operation method |
US5688966A (en) | 1996-07-26 | 1997-11-18 | E. I. Du Pont De Nemours And Company | Compounds and method for synthesizing sulfoindocyanine dyes |
US6303758B1 (en) * | 1996-11-08 | 2001-10-16 | Matsushita Electric Industrial Co., Ltd. | Dye-labeled and polymerized antibody and method for preparing the same |
US6303759B1 (en) * | 1996-11-08 | 2001-10-16 | Matsushita Electric Industrial Co., Ltd. | Dye-labeled and polymerized antibody and method for preparing the same |
US6027709A (en) | 1997-01-10 | 2000-02-22 | Li-Cor Inc. | Fluorescent cyanine dyes |
US5877310A (en) | 1997-04-25 | 1999-03-02 | Carnegie Mellon University | Glycoconjugated fluorescent labeling reagents |
AU7221398A (en) † | 1997-04-29 | 1998-11-24 | Nycomed Imaging As | Method of demarcating tissue |
US5986086A (en) | 1997-06-20 | 1999-11-16 | Amersham Pharmacia Biotech Inc. | Non-sulfonated cyanine dyes for labeling nucleosides and nucleotides |
US6133445A (en) | 1997-12-17 | 2000-10-17 | Carnegie Mellon University | Rigidized trimethine cyanine dyes |
US7250517B2 (en) * | 1998-04-08 | 2007-07-31 | Ewald A. Terpetschnig | Luminescent compounds |
US6538129B1 (en) * | 1999-04-07 | 2003-03-25 | Ewald A. Terpetschnig | Luminescent compounds |
WO1999051702A1 (en) | 1998-04-08 | 1999-10-14 | Terpetschnig Ewald A | Luminescent compounds |
US6002003A (en) | 1998-04-14 | 1999-12-14 | Beckman Instruments, Inc. | Cyanine dye activating group with improved coupling selectivity |
GB9812596D0 (en) | 1998-06-11 | 1998-08-12 | Amersham Pharm Biotech Uk Ltd | Energy transfer assay method |
US6114350A (en) | 1999-04-19 | 2000-09-05 | Nen Life Science Products, Inc. | Cyanine dyes and synthesis methods thereof |
US6664047B1 (en) | 1999-04-30 | 2003-12-16 | Molecular Probes, Inc. | Aza-benzazolium containing cyanine dyes |
EP1212375A2 (en) * | 1999-06-09 | 2002-06-12 | Carnegie-Mellon University | Ph sensitive cyanine dyes as reactive fluorescent reagents |
ATE435262T1 (en) | 1999-07-02 | 2009-07-15 | Visen Medical Inc | FLUORESCENT CYANINE LABELS WITH A SULPHAMIDO BRIDGE |
WO2001002374A1 (en) | 1999-07-06 | 2001-01-11 | Surromed, Inc. | Bridged fluorescent dyes, their preparation and their use in assays |
DE19937024A1 (en) | 1999-08-05 | 2001-02-08 | Bayer Ag | Use of acylsulfonamido substituted polymethine dyes as fluorescent dyes and / or markers |
ATE296828T1 (en) | 1999-09-20 | 2005-06-15 | Fuji Photo Film Co Ltd | COMPOUNDS FOR FLUORESCENCE LABELING |
DE19957320A1 (en) * | 1999-11-29 | 2001-05-31 | Febit Ferrarius Biotech Gmbh | Dynamic sequencing of nucleic acid by hybridization, useful e.g. for research or detecting mutations, includes several hybridization cycles using progressively longer probes |
US6977306B2 (en) * | 2000-05-02 | 2005-12-20 | Sumitomo Chemical Company, Limited | Citalopram hydrobromide crystal and method for crystallization thereof |
US6342326B1 (en) * | 2000-05-10 | 2002-01-29 | Beckman Coulter, Inc. | Synthesis and use of acyl fluorides of cyanine dyes |
DE10046215B4 (en) | 2000-09-19 | 2004-04-15 | Institut für Chemo- und Biosensorik Münster e.V. i.Ins. | Fluorochromes and their use |
WO2002026980A2 (en) | 2000-09-27 | 2002-04-04 | Lexicon Genetics Incorporated | Human ion-exchanger proteins and polynucleotides encoding t he same |
DE60126297T2 (en) | 2000-09-29 | 2007-11-15 | Molecular Probes, Inc., Eugene | MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES |
EP1209205A1 (en) * | 2000-11-28 | 2002-05-29 | Innosense S.r.l. | Improved process and method for the preparation of asymetric monofunctionalised indocyanine labelling reagents and obtained compounds |
US6962992B2 (en) | 2000-12-20 | 2005-11-08 | Molecullar Probes, Inc. | Crown ether derivatives |
US6972326B2 (en) | 2001-12-03 | 2005-12-06 | Molecular Probes, Inc. | Labeling of immobilized proteins using dipyrrometheneboron difluoride dyes |
US7615646B2 (en) | 2002-05-10 | 2009-11-10 | Carnegie Mellon University | Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups |
WO2004104185A1 (en) | 2003-05-08 | 2004-12-02 | Xcyte Therapies, Inc. | Generation and isolation of antigen-specific t cells |
EP2223086B2 (en) * | 2007-12-14 | 2016-06-01 | Biotium Inc. | Fluorescent compounds - labeling dyes |
-
2001
- 2001-09-28 DE DE2001626297 patent/DE60126297T2/en not_active Expired - Fee Related
- 2001-09-28 AT AT01975541T patent/ATE352586T2/en active
- 2001-09-28 EP EP01975541.2A patent/EP1322710B2/en not_active Expired - Lifetime
- 2001-09-28 AU AU2001294859A patent/AU2001294859A1/en not_active Abandoned
- 2001-09-28 DE DE2001975541 patent/DE01975541T9/en active Active
- 2001-09-28 WO PCT/US2001/030404 patent/WO2002026891A1/en active IP Right Grant
- 2001-09-28 EP EP20100183563 patent/EP2325263B1/en not_active Expired - Lifetime
- 2001-09-28 CA CA 2423806 patent/CA2423806C/en not_active Expired - Lifetime
- 2001-09-29 US US09/968,401 patent/US6977305B2/en not_active Expired - Lifetime
- 2001-10-01 US US09/969,853 patent/US6974873B2/en not_active Expired - Lifetime
-
2005
- 2005-06-10 US US11/150,596 patent/US7566790B2/en not_active Expired - Lifetime
- 2005-12-20 US US11/313,890 patent/US7790893B2/en not_active Expired - Lifetime
-
2007
- 2007-02-14 US US11/675,033 patent/US7671214B2/en not_active Expired - Lifetime
- 2007-02-14 US US11/675,030 patent/US20070178511A1/en not_active Abandoned
- 2007-02-14 US US11/675,037 patent/US7820824B2/en not_active Expired - Lifetime
-
2008
- 2008-05-29 US US12/129,641 patent/US8614302B2/en not_active Expired - Lifetime
- 2008-05-29 US US12/129,671 patent/US7927830B2/en not_active Expired - Fee Related
-
2010
- 2010-10-18 US US12/906,304 patent/US8252932B2/en not_active Expired - Lifetime
-
2012
- 2012-07-24 US US13/556,643 patent/US8569506B2/en not_active Expired - Lifetime
-
2013
- 2013-09-18 US US14/030,835 patent/US9018396B2/en not_active Expired - Fee Related
-
2015
- 2015-03-13 US US14/656,992 patent/US20150247785A1/en not_active Abandoned
- 2015-04-15 US US14/687,584 patent/US9423323B2/en not_active Expired - Lifetime
-
2016
- 2016-08-16 US US15/237,853 patent/US20160356681A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2423806A1 (en) | Modified carbocyanine dyes and their conjugates | |
JP2809340B2 (en) | Covalent cyanine dye oligonucleotide conjugate | |
US7038063B2 (en) | Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis | |
US5863753A (en) | Chemically reactive unsymmetrical cyanine dyes and their conjugates | |
JP4916042B2 (en) | Sulfonated xanthene derivatives | |
US20110143337A1 (en) | Unsymmetrical cyanine dimer compounds and their application | |
US7776529B2 (en) | Methine-substituted cyanine dye compounds | |
US20090004641A1 (en) | Site-specific labeling of affinity peptides in fusion proteins | |
AU2006200511B2 (en) | Modified Carbocyanine Dyes and Their Conjugates | |
FR2959228A1 (en) | NUCLEOTIDES MODIFIED | |
EP1801165B1 (en) | Modified carbocyanine dyes and their conjugates | |
US6979575B1 (en) | Fluorochromes for labelling biomolecules and polymer particles and bioanalytical and screening methods based thereon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20210928 |